InvestorsHub Logo
Followers 5
Posts 291
Boards Moderated 0
Alias Born 11/07/2014

Re: None

Sunday, 12/24/2017 1:15:47 PM

Sunday, December 24, 2017 1:15:47 PM

Post# of 721596
https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-017-0597-8

"MSCs have been implicated in the promotion of tumour growth in numerous cancer types such as follicular lymphoma [24], head and neck carcinoma [25], glioma [34], breast [26], gastric [35], colon [36] and prostate cancer [27]."

Could LP be pushing for conditional approval for all cancers with mesenchymal subtypes ? Or is that too far out on left field ?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News